Journal Article
. 2013 Apr; 210(4):743-55.
doi: 10.1084/jem.20121190.

Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin

Michael A Curran 1 Theresa L Geiger  Welby Montalvo  Myoungjoo Kim  Steven L Reiner  Aymen Al-Shamkhani  Joseph C Sun  James P Allison  
Affiliations
  • PMID: 23547098
  •     48 References
  •     75 citations

Abstract

4-1BB agonist antibody treatment induces a population of KLRG1(+) T cells that infiltrate melanoma tumors. We investigated the origin and function of these cells, as well as their place within established T cell paradigms. We find that these T cells, particularly the CD4 lineage, represent a novel phenotype characterized by enhanced, multipotent cytotoxicity. Distinct from described polarities, this T cell phenotype is driven by the T-box transcription factor Eomesodermin. Formation of this phenotype requires 4-1BB signaling on both T and antigen-presenting cells and the resulting production of the cytokines IL-27, IL-15, and IL-10. Furthermore, we find CD4(+) T cells bearing the signature features of this phenotype in the livers of mice infected with both bacterial and viral intracellular pathogens, suggesting a role for these cells in infectious immunity. These T cells constitute a novel phenotype that resolves multiple questions associated with 4-1BB activation, including how 4-1BB enhances tumor-specific cytotoxicity and how 4-1BB can promote tumor immunity while repressing autoimmunity.

4-1BB-mediated immunotherapy of rheumatoid arthritis.
Su K Seo, Jae H Choi, +6 authors, Byoung S Kwon.
Nat Med, 2004 Sep 28; 10(10). PMID: 15448685
Highly Cited.
4-1BB (CD137) is required for rapid clearance of Listeria monocytogenes infection.
Sang-C Lee, Seong-A Ju, +6 authors, Byung S Kim.
Infect Immun, 2005 Jul 26; 73(8). PMID: 16041031    Free PMC article.
IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms.
Sophie Lucas, Nico Ghilardi, Ji Li, Frédéric J de Sauvage.
Proc Natl Acad Sci U S A, 2003 Dec 06; 100(25). PMID: 14657353    Free PMC article.
Highly Cited.
Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.
Vadim Y Taraban, Tania F Rowley, +6 authors, Aymen Al-Shamkhani.
Eur J Immunol, 2003 Jan 09; 32(12). PMID: 12516549
IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells.
Gopal Murugaiyan, Akanksha Mittal, +3 authors, Howard L Weiner.
J Immunol, 2009 Jul 25; 183(4). PMID: 19625647    Free PMC article.
Highly Cited.
Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease.
Yonglian Sun, Helen M Chen, +4 authors, Yang-Xin Fu.
Nat Med, 2002 Nov 12; 8(12). PMID: 12426559
Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb.
Betty Li, Jianmin Lin, +2 authors, Karin Jooss.
Clin Immunol, 2007 Aug 21; 125(1). PMID: 17706463
Reprogramming of IL-10 activity and signaling by IFN-gamma.
Carmen Herrero, Xiaoyu Hu, +4 authors, Lionel B Ivashkiv.
J Immunol, 2003 Nov 11; 171(10). PMID: 14607900
Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production.
Michael A Curran, Myoungjoo Kim, +2 authors, James P Allison.
PLoS One, 2011 May 12; 6(4). PMID: 21559358    Free PMC article.
Highly Cited.
Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease.
Gloria H Y Lin, Bradley J Sedgmen, +3 authors, Tania H Watts.
J Immunol, 2009 Jan 07; 182(2). PMID: 19124736
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts.
Sergio A Quezada, Tyler R Simpson, +9 authors, James P Allison.
J Exp Med, 2010 Feb 17; 207(3). PMID: 20156971    Free PMC article.
Highly Cited.
Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
J A Johnston, C M Bacon, +7 authors, J D Giri.
Proc Natl Acad Sci U S A, 1995 Sep 12; 92(19). PMID: 7568001    Free PMC article.
A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma.
K Shuai, G R Stark, I M Kerr, J E Darnell.
Science, 1993 Sep 24; 261(5129). PMID: 7690989
Highly Cited.
Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death.
J C Hurtado, Y J Kim, B S Kwon.
J Immunol, 1997 Mar 15; 158(6). PMID: 9058792
Marked expansion of CD11c+CD8+ T-cells in melanoma-bearing mice induced by anti-4-1BB monoclonal antibody.
Seong-A Ju, Sang-Min Park, +2 authors, Byung-Sam Kim.
Mol Cells, 2007 Sep 12; 24(1). PMID: 17846508
Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27.
Noriko Morishima, Toshiyuki Owaki, +3 authors, Takayuki Yoshimoto.
J Immunol, 2005 Jul 22; 175(3). PMID: 16034109
Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells.
Toshiro Futagawa, Hisaya Akiba, +4 authors, Ko Okumura.
Int Immunol, 2002 Feb 28; 14(3). PMID: 11867564
CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.
Harry Z Qui, Adam T Hagymasi, +8 authors, Adam J Adler.
J Immunol, 2011 Sep 02; 187(7). PMID: 21880986    Free PMC article.
IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells.
Caroline Diveu, Mandy J McGeachy, +10 authors, Robert A Kastelein.
J Immunol, 2009 Apr 22; 182(9). PMID: 19380822
Highly Cited.
Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells.
John J O'Shea, William E Paul.
Science, 2010 Feb 27; 327(5969). PMID: 20185720    Free PMC article.
Highly Cited. Review.
4-1BB functions as a survival factor in dendritic cells.
Beom K Choi, Young H Kim, +5 authors, Byoung S Kwon.
J Immunol, 2009 Mar 21; 182(7). PMID: 19299708    Free PMC article.
Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity.
Ergun Kocak, Kenneth Lute, +8 authors, Yang Liu.
Cancer Res, 2006 Jul 20; 66(14). PMID: 16849577
Immune responses in 4-1BB (CD137)-deficient mice.
Byoung S Kwon, Jose C Hurtado, +7 authors, Dass S Vinay.
J Immunol, 2002 May 23; 168(11). PMID: 12023342
Costimulation of CD28- T lymphocytes by 4-1BB ligand.
M A DeBenedette, A Shahinian, T W Mak, T H Watts.
J Immunol, 1997 Jan 15; 158(2). PMID: 8992967
Immune regulation by 4-1BB and 4-1BBL: complexities and challenges.
Chao Wang, Gloria H Y Lin, Ann J McPherson, Tania H Watts.
Immunol Rev, 2009 May 12; 229(1). PMID: 19426223
Highly Cited. Review.
Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function.
Jessica Ann Hernandez-Chacon, Yufeng Li, +5 authors, Laszlo G Radvanyi.
J Immunother, 2011 Mar 11; 34(3). PMID: 21389874    Free PMC article.
Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.
Ying Xie, Akgül Akpinarli, +6 authors, Paul Andrew Antony.
J Exp Med, 2010 Feb 17; 207(3). PMID: 20156973    Free PMC article.
Highly Cited.
Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors.
Michael A Curran, James P Allison.
Cancer Res, 2009 Sep 10; 69(19). PMID: 19738077    Free PMC article.
Cutting edge: a key pathogenic role of IL-27 in T cell- mediated hepatitis.
Juergen Siebler, Stefan Wirtz, +4 authors, Markus F Neurath.
J Immunol, 2007 Dec 22; 180(1). PMID: 18096999
The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin.
Rajesh R Rao, Qingsheng Li, Kunle Odunsi, Protul A Shrikant.
Immunity, 2010 Jan 12; 32(1). PMID: 20060330    Free PMC article.
Highly Cited.
Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-β is mediated by suppression of eomesodermin.
Kenji Ichiyama, Takashi Sekiya, +8 authors, Akihiko Yoshimura.
Immunity, 2011 May 24; 34(5). PMID: 21600798
Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin.
Andrew M Intlekofer, Arnob Banerjee, +7 authors, Steven L Reiner.
Science, 2008 Jul 19; 321(5887). PMID: 18635804    Free PMC article.
Highly Cited.
The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.
David H Lynch.
Immunol Rev, 2008 Mar 28; 222. PMID: 18364008
Review.
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis.
Yonglian Sun, Xiaoqi Lin, +4 authors, Yang-Xin Fu.
J Immunol, 2002 Jan 22; 168(3). PMID: 11801689
4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.
W W Shuford, K Klussman, +11 authors, R S Mittler.
J Exp Med, 1997 Jul 07; 186(1). PMID: 9206996    Free PMC article.
Highly Cited.
Constitutive activation of Wnt signaling favors generation of memory CD8 T cells.
Dong-Mei Zhao, Shuyang Yu, +5 authors, Hai-Hui Xue.
J Immunol, 2009 Dec 23; 184(3). PMID: 20026746    Free PMC article.
4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms.
Beom K Choi, Tatsuhiko Asai, +2 authors, Byoung S Kwon.
Cytokine, 2006 Aug 11; 34(5-6). PMID: 16899371
Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ.
Juan Dubrot, Francisca Milheiro, +11 authors, Ignacio Melero.
Cancer Immunol Immunother, 2010 Mar 26; 59(8). PMID: 20336294
Generating diversity: transcriptional regulation of effector and memory CD8 T-cell differentiation.
Rachel L Rutishauser, Susan M Kaech.
Immunol Rev, 2010 Jun 12; 235(1). PMID: 20536566
Review.
IL-27 inhibits the development of regulatory T cells via STAT3.
Magdalena Huber, Vera Steinwald, +5 authors, Michael Lohoff.
Int Immunol, 2007 Dec 25; 20(2). PMID: 18156621
SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicity.
Michael Bots, Ingrid G M Kolfschoten, +9 authors, Jan Paul Medema.
Blood, 2004 Sep 30; 105(3). PMID: 15454490
4-1BB triggering ameliorates experimental autoimmune encephalomyelitis by modulating the balance between Th17 and regulatory T cells.
Young H Kim, Beom K Choi, +8 authors, Byoung S Kwon.
J Immunol, 2011 Jul 01; 187(3). PMID: 21715692
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Jienny Lee, Eun-Na Lee, +9 authors, Sung-Joo Kim.
Immunol Lett, 2005 Jul 20; 101(2). PMID: 16026855
STAT3 is indispensable to IL-27-mediated cell proliferation but not to IL-27-induced Th1 differentiation and suppression of proinflammatory cytokine production.
Toshiyuki Owaki, Masayuki Asakawa, +5 authors, Takayuki Yoshimoto.
J Immunol, 2008 Feb 23; 180(5). PMID: 18292512
Evaluating the cellular targets of anti-4-1BB agonist antibody during immunotherapy of a pre-established tumor in mice.
Gloria H Y Lin, Yuanqing Liu, +3 authors, Tania H Watts.
PLoS One, 2010 Jun 15; 5(6). PMID: 20543982    Free PMC article.
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype.
Daniel Hirschhorn-Cymerman, Sadna Budhu, +10 authors, Jedd D Wolchok.
J Exp Med, 2012 Sep 26; 209(11). PMID: 23008334    Free PMC article.
Distal regions of the human IFNG locus direct cell type-specific expression.
Patrick L Collins, Shaojing Chang, +7 authors, Thomas M Aune.
J Immunol, 2010 Jun 25; 185(3). PMID: 20574006    Free PMC article.
4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses.
J T Tan, J K Whitmire, +2 authors, C P Larsen.
J Immunol, 1999 Oct 21; 163(9). PMID: 10528187
Modulation of inflammation by interleukin-27.
Markus Bosmann, Peter A Ward.
J Leukoc Biol, 2013 Aug 02; 94(6). PMID: 23904441    Free PMC article.
Review.
Therapeutic PD-1 pathway blockade augments with other modalities of immunotherapy T-cell function to prevent immune decline in ovarian cancer.
Jaikumar Duraiswamy, Gordon J Freeman, George Coukos.
Cancer Res, 2013 Aug 27; 73(23). PMID: 23975756    Free PMC article.
Highly Cited.
The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte response.
Zhenzhen Liu, Jianhua Yu, William E Carson, Xue-Feng Bai.
Am J Transl Res, 2013 Aug 27; 5(5). PMID: 23977407    Free PMC article.
CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of glioma.
Katherine A Murphy, Jami R Erickson, +6 authors, John R Ohlfest.
J Immunol, 2013 Dec 03; 192(1). PMID: 24293627    Free PMC article.
Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.
Wenting Huang, Kritika Kachapati, +8 authors, William M Ridgway.
J Autoimmun, 2014 Feb 22; 50. PMID: 24556277    Free PMC article.
Inflammation enhances IL-2 driven differentiation of cytolytic CD4 T cells.
Aspen M Workman, Ashley K Jacobs, +2 authors, Deborah M Brown.
PLoS One, 2014 Mar 04; 9(2). PMID: 24586481    Free PMC article.
HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity.
Saravana Kanagavelu, James M Termini, +6 authors, Geoffrey W Stone.
PLoS One, 2014 Mar 04; 9(2). PMID: 24587225    Free PMC article.
CD4+ T Cells: guardians of the phagosome.
Noah J Tubo, Marc K Jenkins.
Clin Microbiol Rev, 2014 Apr 04; 27(2). PMID: 24696433    Free PMC article.
Review.
Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy.
Chang Song, Kavitha Sadashivaiah, +3 authors, Arnob Banerjee.
Oncoimmunology, 2014 May 03; 3(1). PMID: 24790793    Free PMC article.
Hematopoietic not systemic impairment of Roquin expression accounts for intestinal inflammation in Roquin-deficient mice.
Dina Montufar-Solis, Nadarajah Vigneswaran, +2 authors, John R Klein.
Sci Rep, 2014 May 13; 4. PMID: 24815331    Free PMC article.
Characterization of T-bet and eomes in peripheral human immune cells.
James J Knox, Gabriela L Cosma, Michael R Betts, Laura M McLane.
Front Immunol, 2014 May 27; 5. PMID: 24860576    Free PMC article.
Highly Cited.
KLRG+ invariant natural killer T cells are long-lived effectors.
Kanako Shimizu, Yusuke Sato, +13 authors, Shin-ichiro Fujii.
Proc Natl Acad Sci U S A, 2014 Aug 15; 111(34). PMID: 25118276    Free PMC article.
Costimulatory molecules as vaccine adjuvants: to 4-1BB or not to 4-1BB?
Khalidur Rahman, Smita S Iyer.
Cell Mol Immunol, 2014 Sep 10; 12(4). PMID: 25195512    Free PMC article.
Review.
4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.
Douglas C Macdonald, Alastair Hotblack, +3 authors, William C Rosenberg.
J Immunol, 2014 Oct 12; 193(10). PMID: 25305314    Free PMC article.
CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
Mustafa Diken, Sebastian Boegel, +6 authors, Sebastian Kreiter.
Hum Vaccin Immunother, 2014 Dec 09; 10(10). PMID: 25483671    Free PMC article.
The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy.
Ming-Song Li, Zhenzhen Liu, +3 authors, Xue-Feng Bai.
Immunotherapy, 2015 Feb 26; 7(2). PMID: 25713993    Free PMC article.
Review.
Overcoming T cell exhaustion in infection and cancer.
Kristen E Pauken, E John Wherry.
Trends Immunol, 2015 Mar 24; 36(4). PMID: 25797516    Free PMC article.
Highly Cited. Review.
NKT cell-targeted vaccination plus anti-4-1BB antibody generates persistent CD8 T cell immunity against B cell lymphoma.
Takumi Kobayashi, Brianna L Doff, +2 authors, Stephen R Mattarollo.
Oncoimmunology, 2015 May 08; 4(3). PMID: 25949907    Free PMC article.
Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia.
Susan Johnson, Michael Eller, +13 authors, Hendrik Streeck.
J Virol, 2015 May 15; 89(15). PMID: 25972560    Free PMC article.
Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb.
Bettina Weigelin, Elixabet Bolaños, +10 authors, Ignacio Melero.
Proc Natl Acad Sci U S A, 2015 Jun 03; 112(24). PMID: 26034288    Free PMC article.
4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity.
Todd Bartkowiak, Michael A Curran.
Front Oncol, 2015 Jun 25; 5. PMID: 26106583    Free PMC article.
Highly Cited. Review.
IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4+ T cells and promoting CTL persistence in a murine model of plasmacytoma.
Lixin Wang, Jin-Qing Liu, +3 authors, Xue-Feng Bai.
Oncoimmunology, 2015 Jul 04; 4(7). PMID: 26140236    Free PMC article.
A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients.
Benjamin J D Weist, Patrizia Wehler, +6 authors, Nina Babel.
Kidney Int, 2015 Jul 30; 88(6). PMID: 26221751
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine.
Todd Bartkowiak, Shailbala Singh, +6 authors, Michael A Curran.
Proc Natl Acad Sci U S A, 2015 Sep 10; 112(38). PMID: 26351680    Free PMC article.
Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation.
Ben J E Raveney, Shinji Oki, +4 authors, Takashi Yamamura.
Nat Commun, 2015 Oct 06; 6. PMID: 26436530    Free PMC article.
CD70 and IFN-1 selectively induce eomesodermin or T-bet and synergize to promote CD8+ T-cell responses.
Han Dong, Nathan A Franklin, +3 authors, Timothy N J Bullock.
Eur J Immunol, 2015 Oct 16; 45(12). PMID: 26461455    Free PMC article.
Innate and Adaptive Immune Regulation During Chronic Viral Infections.
Elina I Zuniga, Monica Macal, Gavin M Lewis, James A Harker.
Annu Rev Virol, 2016 Mar 10; 2(1). PMID: 26958929    Free PMC article.
Highly Cited. Review.
The Differentiation and Protective Function of Cytolytic CD4 T Cells in Influenza Infection.
Deborah M Brown, Anna T Lampe, Aspen M Workman.
Front Immunol, 2016 Mar 26; 7. PMID: 27014272    Free PMC article.
Review.
4-1BB agonism: adding the accelerator to cancer immunotherapy.
Cariad Chester, Siddhant Ambulkar, Holbrook E Kohrt.
Cancer Immunol Immunother, 2016 Apr 02; 65(10). PMID: 27034234    Free PMC article.
Review.
CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses.
Bhushan Dharmadhikari, Meihui Wu, +5 authors, Herbert Schwarz.
Oncoimmunology, 2016 May 04; 5(4). PMID: 27141396    Free PMC article.
Review.
Heterologous Vaccination and Checkpoint Blockade Synergize To Induce Antileukemia Immunity.
Luke S Manlove, Jason M Schenkel, +4 authors, Michael A Farrar.
J Immunol, 2016 May 18; 196(11). PMID: 27183622    Free PMC article.
What Happens in the Thymus Does Not Stay in the Thymus: How T Cells Recycle the CD4+-CD8+ Lineage Commitment Transcriptional Circuitry To Control Their Function.
Melanie S Vacchio, Rémy Bosselut.
J Immunol, 2016 Jun 05; 196(12). PMID: 27260768    Free PMC article.
Review.
Driving an improved CAR for cancer immunotherapy.
Xiaopei Huang, Yiping Yang.
J Clin Invest, 2016 Jul 28; 126(8). PMID: 27454296    Free PMC article.
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition.
Leonid Cherkassky, Aurore Morello, +5 authors, Prasad S Adusumilli.
J Clin Invest, 2016 Jul 28; 126(8). PMID: 27454297    Free PMC article.
Highly Cited.
Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination.
Anke Redeker, Ramon Arens.
Front Immunol, 2016 Sep 23; 7. PMID: 27656185    Free PMC article.
Review.
Cytotoxic CD4 T Cells: Differentiation, Function, and Application to Dengue Virus Infection.
Yuan Tian, Alessandro Sette, Daniela Weiskopf.
Front Immunol, 2016 Dec 23; 7. PMID: 28003809    Free PMC article.
Review.
NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection.
Nikki B Marshall, Allen M Vong, +8 authors, Susan L Swain.
J Immunol, 2016 Dec 30; 198(3). PMID: 28031335    Free PMC article.
T-Bet independent development of IFNγ secreting natural T helper 1 cell population in the absence of Itk.
Arun K Kannan, Sonia Mohinta, +4 authors, Avery August.
Sci Rep, 2017 Apr 14; 7. PMID: 28406139    Free PMC article.
Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer.
Anusha-Preethi Ganesan, James Clarke, +14 authors, Christian H Ottensmeier.
Nat Immunol, 2017 Jun 20; 18(8). PMID: 28628092    Free PMC article.
Highly Cited.
Eomesodermin promotes the development of type 1 regulatory T (TR1) cells.
Ping Zhang, Jason S Lee, +24 authors, Geoffrey R Hill.
Sci Immunol, 2017 Jul 25; 2(10). PMID: 28738016    Free PMC article.
Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy.
Aki Furusawa, John Reiser, +2 authors, Arnob Banerjee.
J Immunother, 2017 Dec 23; 41(2). PMID: 29271784    Free PMC article.
An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells.
Payal Mittal, Rebecca Abblett, +8 authors, Adam J Adler.
J Immunol, 2018 Jan 07; 200(4). PMID: 29305435    Free PMC article.
Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses.
Il-Kyu Choi, Zhe Wang, +10 authors, Baochun Zhang.
Proc Natl Acad Sci U S A, 2018 Jan 10; 115(4). PMID: 29311309    Free PMC article.
Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential.
Dmitri I Kotov, Jessica A Kotov, Michael F Goldberg, Marc K Jenkins.
J Immunol, 2018 Feb 14; 200(6). PMID: 29436413    Free PMC article.
Current perspectives of SA-4-1BBL in immune modulation during cancer.
Shu-Ni Zhou, Rui-Zhi Ran, Li-Li Tan, Hao Guo.
Exp Ther Med, 2018 Feb 20; 15(3). PMID: 29456671    Free PMC article.
The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes.
Yasmina Serroukh, Chunyan Gu-Trantien, +15 authors, Arnaud Marchant.
Elife, 2018 Mar 01; 7. PMID: 29488879    Free PMC article.
IL-27 regulates the number, function and cytotoxic program of antiviral CD4 T cells and promotes cytomegalovirus persistence.
Ellen J Wehrens, Kurt A Wong, +3 authors, Elina I Zuniga.
PLoS One, 2018 Jul 26; 13(7). PMID: 30044874    Free PMC article.
New strategies in immunotherapy for lung cancer: beyond PD-1/PD-L1.
Nicolas Villanueva, Lyudmila Bazhenova.
Ther Adv Respir Dis, 2018 Sep 15; 12. PMID: 30215300    Free PMC article.
Review.
Dendritic cell maturation in the corneal epithelium with onset of type 2 diabetes is associated with tumor necrosis factor receptor superfamily member 9.
Neil S Lagali, Reza A Badian, +5 authors, Olov Rolandsson.
Sci Rep, 2018 Sep 27; 8(1). PMID: 30250206    Free PMC article.
A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.
Pradeep K Rai, Sathi Babu Chodisetti, +5 authors, Javed N Agrewala.
J Transl Med, 2018 Oct 12; 16(1). PMID: 30305097    Free PMC article.
High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes.
Fanny Onodi, Chahrazed Maherzi-Mechalikh, +13 authors, Corinne Tanchot.
Front Oncol, 2018 Nov 30; 8. PMID: 30483475    Free PMC article.
Extrapituitary prolactin promotes generation of Eomes-positive helper T cells mediating neuroinflammation.
Chenyang Zhang, Ben J E Raveney, +3 authors, Takashi Yamamura.
Proc Natl Acad Sci U S A, 2019 Oct 02; 116(42). PMID: 31570595    Free PMC article.
Allogeneic dendritic cells induce potent antitumor immunity by activating KLRG1+CD8 T cells.
Chao Wang, Zhengyuan Li, +6 authors, Minghui Zhang.
Sci Rep, 2019 Oct 31; 9(1). PMID: 31664180    Free PMC article.
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity.
Mikhail Binnewies, Adriana M Mujal, +15 authors, Matthew F Krummel.
Cell, 2019 Apr 09; 177(3). PMID: 30955881    Free PMC article.
Highly Cited.
Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers.
Stephanie Dorta-Estremera, Renee L Chin, +7 authors, K Jagannadha Sastry.
Cancer Res, 2018 Jul 29; 78(18). PMID: 30054333    Free PMC article.
IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses.
Rosa M Santana Carrero, Figen Beceren-Braun, +6 authors, Kimberly S Schluns.
Proc Natl Acad Sci U S A, 2018 Dec 28; 116(2). PMID: 30587590    Free PMC article.
Costimulation Induces CD4 T Cell Antitumor Immunity via an Innate-like Mechanism.
Crystal Morales Del Valle, Joseph R Maxwell, +5 authors, Anthony T Vella.
Cell Rep, 2019 May 03; 27(5). PMID: 31042471    Free PMC article.
A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis.
Douglas B Johnson, Wyatt J McDonnell, +30 authors, Justin M Balko.
Nat Med, 2019 Jul 25; 25(8). PMID: 31332390    Free PMC article.
Highly Cited.
Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent Pathway.
Todd Bartkowiak, Ashvin R Jaiswal, +8 authors, Michael A Curran.
Clin Cancer Res, 2018 Jan 06; 24(5). PMID: 29301830    Free PMC article.
Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology.
Paul David, Malgorzata Drabczyk-Pluta, +24 authors, Gennadiy Zelinskyy.
PLoS Pathog, 2020 Apr 01; 16(3). PMID: 32226027    Free PMC article.
Decoding the Role of Interleukin-30 in the Crosstalk Between Cancer and Myeloid Cells.
Emma Di Carlo.
Cells, 2020 Mar 08; 9(3). PMID: 32143355    Free PMC article.
Review.
4-1BB Agonism Combined With PD-L1 Blockade Increases the Number of Tissue-Resident CD8+ T Cells and Facilitates Tumor Abrogation.
Qiu-Xia Qu, Xin-Yun Zhu, +4 authors, Cheng Chen.
Front Immunol, 2020 May 12; 11. PMID: 32391001    Free PMC article.
The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer.
Takeo Shibata, Benjamin J Lieblong, Toshiyuki Sasagawa, Mayumi Nakagawa.
Cancer Treat Rev, 2019 Jul 16; 78. PMID: 31302573    Free PMC article.
Review.
Therapeutic Vaccines for HPV-Associated Malignancies.
Claire Smalley Rumfield, Nicholas Roller, +2 authors, Caroline Jochems.
Immunotargets Ther, 2020 Oct 30; 9. PMID: 33117742    Free PMC article.
Review.
Bone Morphogenic Proteins Are Immunoregulatory Cytokines Controlling FOXP3+ Treg Cells.
Lauren M Browning, Caroline Miller, +6 authors, Piotr Kraj.
Cell Rep, 2020 Oct 08; 33(1). PMID: 33027660    Free PMC article.
Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models.
Steven A Greenberg, Sek Won Kong, Evan Thompson, Stefano V Gulla.
Oncotarget, 2019 Mar 13; 10(14). PMID: 30858925    Free PMC article.
Is AAV-delivered IL-27 a potential immunotherapeutic for cancer?
Jin-Qing Liu, Jianmin Zhu, +6 authors, Xue-Feng Bai.
Am J Cancer Res, 2020 Dec 10; 10(11). PMID: 33294255    Free PMC article.
Review.
Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20-CCR6 pathway.
Jingyao Lian, Saisai Liu, +4 authors, Yi Zhang.
Cancer Sci, 2020 Oct 29; 112(1). PMID: 33113266    Free PMC article.
EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia.
Philipp M Roessner, Laura Llaó Cid, +15 authors, Martina Seiffert.
Leukemia, 2021 Feb 03; 35(8). PMID: 33526861    Free PMC article.
B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8+ tumor-infiltrating lymphocytes.
Gihoon You, Yangsoon Lee, +18 authors, Seung-Woo Lee.
Sci Adv, 2021 Feb 02; 7(3). PMID: 33523913    Free PMC article.
EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia.
Laura Llaó-Cid, Philipp M Roessner, +10 authors, Martina Seiffert.
Leukemia, 2021 Mar 19; 35(11). PMID: 33731848    Free PMC article.
A Fas-4-1BB fusion protein converts a death to a pro-survival signal and enhances T cell therapy.
Shannon K Oda, Kristin G Anderson, +8 authors, Philip D Greenberg.
J Exp Med, 2020 Aug 30; 217(12). PMID: 32860705    Free PMC article.
Essential role of a ThPOK autoregulatory loop in the maintenance of mature CD4+ T cell identity and function.
Jayati Basu, Bernardo S Reis, +14 authors, Dietmar J Kappes.
Nat Immunol, 2021 Jul 28; 22(8). PMID: 34312548    Free PMC article.
EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8+ T Cells.
Christopher J Stairiker, Sophia Xiao Pfister, +7 authors, Shahram Salek-Ardakani.
Front Immunol, 2021 Dec 21; 12. PMID: 34925340    Free PMC article.
Bona Fide Th17 Cells without Th1 Functional Plasticity Protect against Influenza.
Kunal Dhume, Caroline M Finn, +7 authors, Karl Kai McKinstry.
J Immunol, 2022 Mar 27; 208(8). PMID: 35338093    Free PMC article.